MacroGenics Net Profit Margin 2012-2025 | MGNX
MacroGenics Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2025-06-30 | $0.17B | $-0.04B | -21.82% |
2025-03-31 | $0.15B | $-0.06B | -36.36% |
2024-12-31 | $0.15B | $-0.07B | -44.67% |
2024-09-30 | $0.14B | $-0.10B | -69.01% |
2024-06-30 | $0.04B | $-0.14B | -331.71% |
2024-03-31 | $0.04B | $-0.02B | -53.49% |
2023-12-31 | $0.06B | $-0.01B | -15.52% |
2023-09-30 | $0.12B | $0.05B | 41.67% |
2023-06-30 | $0.15B | $0.01B | 4.61% |
2023-03-31 | $0.17B | $-0.09B | -55.15% |
2022-12-31 | $0.15B | $-0.12B | -78.29% |
2022-09-30 | $0.09B | $-0.19B | -204.30% |
2022-06-30 | $0.07B | $-0.22B | -325.37% |
2022-03-31 | $0.07B | $-0.22B | -301.39% |
2021-12-31 | $0.08B | $-0.20B | -258.97% |
2021-09-30 | $0.12B | $-0.15B | -124.79% |
2021-06-30 | $0.12B | $-0.13B | -108.40% |
2021-03-31 | $0.11B | $-0.14B | -125.93% |
2020-12-31 | $0.11B | $-0.13B | -123.81% |
2020-09-30 | $0.08B | $-0.16B | -205.19% |
2020-06-30 | $0.08B | $-0.17B | -214.10% |
2020-03-31 | $0.07B | $-0.15B | -220.29% |
2019-12-31 | $0.07B | $-0.15B | -233.85% |
2019-09-30 | $0.06B | $-0.17B | -298.21% |
2019-06-30 | $0.06B | $-0.16B | -268.97% |
2019-03-31 | $0.07B | $-0.17B | -253.03% |
2018-12-31 | $0.06B | $-0.17B | -281.97% |
2018-09-30 | $0.20B | $-0.02B | -10.66% |
2018-06-30 | $0.18B | $-0.03B | -19.10% |
2018-03-31 | $0.16B | $-0.03B | -19.88% |
2017-12-31 | $0.16B | $-0.02B | -12.66% |
2017-09-30 | $0.01B | $-0.16B | -1463.64% |
2017-06-30 | $0.01B | $-0.15B | -1233.33% |
2017-03-31 | $0.09B | $-0.07B | -73.63% |
2016-12-31 | $0.09B | $-0.06B | -64.13% |
2016-09-30 | $0.10B | $-0.05B | -54.74% |
2016-06-30 | $0.11B | $-0.03B | -30.84% |
2016-03-31 | $0.03B | $-0.09B | -284.85% |
2015-12-31 | $0.10B | $-0.02B | -18.81% |
2015-09-30 | $0.10B | $-0.01B | -10.20% |
2015-06-30 | $0.10B | $0.00B | 0.99% |
2015-03-31 | $0.10B | $0.01B | 9.71% |
2014-12-31 | $0.05B | $-0.04B | -80.85% |
2014-09-30 | $0.06B | $-0.02B | -28.07% |
2014-06-30 | $0.06B | $-0.01B | -20.34% |
2014-03-31 | $0.06B | 0 | 0.00% |
2013-12-31 | $0.06B | 0 | 0.00% |
2013-06-30 | $0.04B | $0.00B | -7.69% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.114B | $0.150B |
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
Boston Scientific (BSX) | United States | $157.644B | 37.59 |
Stryker (SYK) | United States | $150.755B | 30.69 |
EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
Medtronic (MDT) | Ireland | $118.256B | 16.67 |
Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
ResMed (RMD) | United States | $41.753B | 29.86 |
GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
Agilent Technologies (A) | United States | $33.605B | 21.91 |
Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
Terumo (TRUMY) | Japan | $26.532B | 31.44 |
Insulet (PODD) | United States | $23.358B | 78.26 |
Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
Smith & Nephew SNATS (SNN) | United Kingdom | $16.337B | 0.00 |
Baxter (BAX) | United States | $12.584B | 9.72 |
Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
Demant (WILYY) | Denmark | $8.121B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
Envista Holdings (NVST) | United States | $3.513B | 24.58 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
ICU Medical (ICUI) | United States | $3.109B | 21.17 |
Haemonetics (HAE) | United States | $2.661B | 11.88 |
LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
Acuren (TIC) | United States | $2.156B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
AtriCure (ATRC) | United States | $1.882B | 0.00 |
Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
Neogen (NEOG) | United States | $1.223B | 19.41 |
Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
InMode (INMD) | Israel | $0.941B | 8.70 |
Valneva SE (VALN) | France | $0.762B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.683B | 0.00 |
SNDL (SNDL) | Canada | $0.649B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
ZimVie (ZIMV) | United States | $0.535B | 20.62 |
Surmodics (SRDX) | United States | $0.496B | 0.00 |
Evolus (EOLS) | United States | $0.495B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
CeriBell (CBLL) | United States | $0.420B | 0.00 |
Owens & Minor (OMI) | United States | $0.387B | 3.43 |
Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
Brainsway (BWAY) | Israel | $0.301B | 61.15 |
Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
Omeros (OMER) | United States | $0.298B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
High Tide (HITI) | Canada | $0.283B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
Cerus (CERS) | United States | $0.255B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
Organigram Global (OGI) | Canada | $0.221B | 0.00 |
Quanterix (QTRX) | United States | $0.218B | 0.00 |
Exagen (XGN) | United States | $0.218B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
Biote (BTMD) | United States | $0.164B | 5.43 |
Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
Jin Medical (ZJYL) | China | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.096B | 12.32 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Apyx Medical (APYX) | United States | $0.079B | 0.00 |
Agape ATP (ATPC) | $0.068B | 0.00 | |
Safety Shot (SHOT) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
ImmuCell (ICCC) | United States | $0.057B | 32.90 |
Veru (VERU) | United States | $0.051B | 0.00 |
Zynex (ZYXI) | United States | $0.050B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 33.67 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Modular Medical (MODD) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.62 |
Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
Senestech (SNES) | United States | $0.023B | 0.00 |
INLIF (INLF) | $0.018B | 0.00 | |
Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Sharps Technology (STSS) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InterCure (INCR) | Israel | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |